Email this Print The management of Sun Pharmaceutical Industries has been asked by the office of the assistant labour commissioner, Maharashtra, to come over for a discussion on October 18 with medical representatives (MRs) of the erstwhile ... Smart Investor, 1 week ago
Sun Pharma: 6 per cent of Ranbaxy medical representatives refusing to file DARs - Indian Express, 1 week ago
Sun Pharma's ex-Ranbaxy sales reps threaten all-India strike against new policies - FiercePharma, 1 month ago
3 images for "ranbaxy industries"
Backed by a Bombay High Court order, drug major Sun Pharmaceutical Industries today said it will release salaries of the erstwhile Ranbaxy medical representatives only if they used a company provided software application to report daily activity ...Business Standard, 1 week ago
Sun Pharmaceutical Industries and Ranbaxy (UK) v Commission (Judgment)  EUECJ T-460/13 (08 September 2016)
[ New search ] [ Help ] JUDGMENT OF THE GENERAL COURT (Ninth Chamber) 8 September 2016 ( * ) (Competition— Agreements, decisions and concerted practices— Market for antidepressant medicinal products containing the active ...Bailii.org, 1 month ago Arrow Group and Arrow Generics v Commission (Judgment)  EUECJ T-467/13 (08 September 2016) Bailii.org, 1 month ago Lundbeck v Commission (Judgment)  EUECJ T-472/13 (08 September 2016) Bailii.org, 1 month ago
India's biggest drug maker Sun Pharmaceutical Industries has tied up with Delhi-based International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a dengue vaccine that targets all four types of dengue viruses that cause disease ...Business Today India, 4 days ago Indian pharma steps up efforts on US safety standards Abu Dhabi National, 1 month ago Wockhardt : Indian pharma steps up efforts on US safety standards 4 Traders, 1 month ago
Sun Pharma, India's best performing stock in last 20 years, on track for worst annual decline since 2008
One executive, Srinivas Lanka, recalls the founder of Sun Pharmaceuticals Industries Ltd. calling more than 100 times over three years with a job offer two decades ago. In the end, Shanghvi won over Lanka, who agreed to leave his job at global ...Financial Express, 1 week ago Dilip Shanghvi, Man Behind India's Best Stock, Now Faces His Greatest Test NDTV, 1 week ago M&A Artist Behind India's Best Stock Now Faces His Greatest Test Financial Express, 1 week ago Sun Pharma to set up R&D unit in M.P. Hindu Business Line, 18 hours ago
As part of the integration of erstwhile Ranbaxy, it was decided to use Target Application as a single platform for DAR for the India field force, Sun Pharma added. Sun Pharma had asked the erstwhile Ranbaxy representatives to switch over to ...NDTV, 1 week ago Sun Pharma To Pay Salary To Ex-Ranbaxy Representatives Using Company App NDTV, 1 week ago
Cushman & Wakefield of Florida to Target HQ Users for Southside Warehouse, Will Be Made Available January 2017 Ranbaxy Pharmaceuticals has put its 244,000-square-foot warehouse facility at 9431 Florida Mining Blvd. E. in Jacksonville, FL on the ...CoStar Group, 3 weeks ago
India's largest drug maker Sun Pharmaceutical Industries Ltd will shut down some of its manufacturing plants in India as well as overseas as the company will continue trimming its large manufacturing base as part of cost optimisation. The decision, ...Businessworld India, 3 weeks ago Sun Pharma profit triples to Rs2,034 crore in Q1 on higher sales of cancer drug [Jerusalem Post (Israel)] Pharmacy Choice, 1 month ago Pharmalot, Pharmalittle: India wants you to know its drugs are safe and effective StatNews.com, 2 months ago
Industrialist Mukesh Ambani was today named India's richest person for a ninth year in a row with a sharp increase in networth to USD 22.7 billion, while Sun Pharma's Dilip Shanghvi was ranked a distant second with a wealth of USD 16.9 billion. ...Smart Investor, 1 month ago Mukesh Ambani India's richest for 9th yr, Shanghvi at 2nd spot Daily Excelsior.com, 1 month ago With $22.7 billion in his kitty, Mukesh Ambani is India's richest Rediff.com, 1 month ago
MUMBAI: A Republican Congresswoman and bitter foe of US presidential candidate Hillary Clinton has dragged Ranbaxy Labs into her latest attack on the Democratic nominee. Congresswoman Marsha Blackburn's letter, a 71-page report embossed with the ...Economic Times, 1 month ago
on your WebpageAdd Widget >Get your members hooked!